Hudson Bay Capital Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Hudson Bay Capital Management’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-75,000	Closed	-$163K	–	1282
2021 Q3	$163K	Buy	+75,000	New	+$163K	﹤0.01%	885

Other funds holding SIOX

JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return

CIA

Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Hudson Bay Capital Management's SIOX Position: Q1 2023 in Review

Hudson Bay Capital Management sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 235,000 shares — an estimated $102K sold.

Hudson Bay Capital Management first reported a position in SIOX in Q2 2015 and held it in 23 quarters. The position peaked at $6.12M in Q3 2020. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

Hudson Bay Capital Management reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Hudson Bay Capital Management sold 235,000 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $102K.
Hudson Bay Capital Management first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2015 and held it in 23 quarters.
Hudson Bay Capital Management's Sio Gene Therapies Inc. Common Stock position peaked at $6.12M in Q3 2020.
4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Hudson Bay Capital Management's 13F filing for Q1 2023, filed 15 May 2023.